StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX)
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report report published on Friday. The firm issued a sell rating on the stock. OCX has been the subject of several other reports. Benchmark dropped their target price on shares of OncoCyte from $9.00 to $5.00 and set a speculative buy […]
More Stories
Analysts Set Expectations for CrowdStrike FY2026 Earnings
CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) – Research analysts at DA Davidson upped their FY2026 earnings per share (EPS)...
William Blair Has Bullish Estimate for CBIZ Q1 Earnings
CBIZ, Inc. (NYSE:CBZ – Free Report) – Stock analysts at William Blair lifted their Q1 2026 EPS estimates for CBIZ...
What is DA Davidson’s Forecast for CrowdStrike Q2 Earnings?
CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) – Analysts at DA Davidson issued their Q2 2026 earnings per share (EPS)...
Equities Analysts Offer Predictions for AMAT Q4 Earnings
Applied Materials, Inc. (NASDAQ:AMAT – Free Report) – Equities research analysts at Zacks Research lowered their Q4 2025 EPS estimates...
Zacks Research Issues Optimistic Estimate for LOW Earnings
Lowe’s Companies, Inc. (NYSE:LOW – Free Report) – Equities researchers at Zacks Research increased their Q2 2026 earnings estimates for...
Zacks Research Issues Negative Estimate for Neogen Earnings
Neogen Co. (NASDAQ:NEOG – Free Report) – Stock analysts at Zacks Research decreased their FY2026 earnings per share (EPS) estimates...